Home  >  Products  >  ASPA (aspartoacylase (Canavan disease)) Blocking Peptide (the N terminal of protein) (100ug)
ASPA (aspartoacylase (Canavan disease)) Blocking Peptide (the N terminal of protein) (100ug)

ASPA (aspartoacylase (Canavan disease)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ASPA antibody (Catalogue #: ARP56072_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP56072
Size: 100 ug
Weight: 36kDa
Gene: 443
Format: Lyophilized powder
Target: The specific function of SASP is not yet known.This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene.
Alternative names: ACY2; ASP
See Full Product Listings >